Back to search results

Educational Program for Lung Cancer Knowledge in American Indian/Alaskan Native Smokers

This study is testing an educational program called the "Lung Toolkit" to see if it helps American Indian and Alaskan Native (AI/AN) cigarette smokers learn more about lung cancer and screening. The Lung Toolkit includes a website and physical materials designed specifically for AI/AN individuals, offering resources on lung health, commercial and traditional tobacco, and community stories. The goal is to see how well people accept the Lung Toolkit and if it improves their knowledge about lung cancer screening. You may be able to join if you are an AI/AN individual between 50 and 80 years old, and have smoked for at least 10 pack-years. The study is planning to enroll 60 participants, but its current status is unclear.

Study design
This interventional study plans to enroll 60 participants to test an educational intervention. It is not specified if it is randomized or blinded.
What's involved
Participants will receive Lung Toolkit materials, including a website link and a physical pouch. They will then have a 60-minute guided review, followed by 30 days of using the materials.
Compensation
Not stated in the trial record.
Follow-up
Your acceptability of the intervention will be measured at day 15 and day 45. Your lung cancer screening knowledge will be measured from the start of the study to day 45.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07615764

An Educational Intervention (Lung Toolkit) for Improving Knowledge About Lung Cancer and Screening Among American Indian and Alaskan Native Cigarette Smokers, Lung PATHS Trial

Not Yet Recruiting
NAAges 50–80InterventionalPrevention
Fred Hutchinson Cancer Center
~60 participants
Updated 2026-05-29 on ClinicalTrials.gov
What's tested:Educational InterventionInterviewQuestionnaire Administration

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of intervention
Measured over At post-guided review assessment (day 15) and post-intervention (day 45)
+1 more outcome measured

Conditions

Lung Carcinoma

Explore related trials

Lung Carcinoma

Where it's being run

1 sites across 1 states
Washington1

Study leadership

  • Matthew Triplette, MD, MPH · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium

Who to contact

Nicolas Anderson
[email protected]
206.667.5434
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Between ages 50-80
Self-identify as AI/AN
Self-reported 10 pack-year smoking history (commercial tobacco i.e. cigarettes)
Ability to understand and willingness to sign an informed consent document

Exclusion

Not between ages 50-80
Having less than a 10 pack-year history of smoking commercial tobacco
Inability to communicate in written and verbal English
Having any cognitive impairment that compromises the ability to provide informed consent

What this trial measures

  • Acceptability of interventionAt post-guided review assessment (day 15) and post-intervention (day 45)

    Acceptability will be evaluated using the Acceptability of Intervention (AIM) assessment score and semi-structured interviews. AIM results will be summarized and presented as a range of score from 1 to 5.

  • Lung cancer screening knowledgeFrom baseline to day 45

    Will be evaluated using a validated measure for assessing lung cancer screening knowledge (Lung Cancer Screening Knowledge Score \[LKS\]-7). Pre- and post-intervention LKS responses will be compared via Cochran-Mantel-Haenszel and Friedman tests.